Prostaglandin

Product Indication Specification Regulatory status
Alprostadil 1. Cyanotic congenital heart disease for pediatrics
2. Peripheral Arterial Occlusive Disease
3. Erectile dysfunction
USP / EP / CN US DMF / CEP / China Reg. No.
/ Canada DMF
Epoprostenol Sodium Primary Pulmonary Hypertension In-house ASMF/China Reg. No.
/ Canada DMF
Limaprost alfadex 1. Ischemic symptoms
2. Lumbar spinal canal stenosis
JP China Reg. No. *
Lubiprostone Chronic idiopathic constipation In-house US DMF
Misoprostol 1. NSAID-induced Ulcers
2. Gastric/Duodenal Ulcers
3. Labour Induction
USP/EP US DMF/ ASMF/ Australia DMF
Misoprostol-HPMC 1% Dispersion 1. NSAID-induced Ulcers
2. Gastric/Duodenal Ulcers
3. Labour Induction
In-house / USP US DMF/ ASMF/ Australia DMF
China Reg. No. / Canada DMF
Treprostinil Diolanime Pulmonary Arterial Hypertension In-house US DMF
Bimatoprost Glaucoma In-house US DMF/ ASMF
/ Canada DMF/ Japan DMF
Latanoprost In-house / USP US DMF/ ASMF
/ Japan DMF/ Australia DMF
/ China IDL / Canada DMF
Latanoprostene Bunod In-house none
Travoprost USP none
Tafluprost In-house US DMF

*  In process

Contact Us